What it's for (Indications)
- Ampicillin + Cloxacillin is indicated for the treatment of various bacterial infections caused by susceptible organisms.
- This combination is particularly useful in situations where both ampicillin-susceptible bacteria and penicillinase-producing staphylococci are either known or suspected to be causative agents.
- Clinical applications include, but are not limited to, respiratory tract infections (e.
- g.
- , bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections (e.
- g.
- , cellulitis, abscesses), gastrointestinal infections, osteomyelitis, and septicemia.
- The broad-spectrum activity of ampicillin combined with cloxacillin's resistance to staphylococcal beta-lactamase provides comprehensive coverage against a range of Gram-positive and Gram-negative pathogens, making it a valuable option for empirical therapy in mixed infections.
- Proper microbiological culturing and susceptibility testing should guide therapy whenever possible to optimize treatment and minimize the development of antibiotic resistance.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | Dosage of ampicillin + cloxacillin must be individualized based on the severity and site of infection, the susceptibility of the causative organisms, and the patient's renal function, age, and body weight. For adults, a common oral dosage for an Amplus 500mg formulation (typically containing 250mg ampicillin and 250mg cloxacillin, or similar ratios) is 250-500mg administered every six hours. In severe infections, the dosage may be increased or administered parenterally (intravenously or intramuscularly) under medical supervision. Pediatric dosages are typically calculated based on body weight. Renal impairment necessitates careful dosage adjustments to prevent accumulation and potential toxicity, as both ampicillin and cloxacillin are primarily excreted via the kidneys. The duration of treatment should be determined by the nature and severity of the infection, generally continuing for at least 48 to 72 hours after the patient becomes asymptomatic, and for a minimum of 7 to 10 days for most bacterial infections, or longer for conditions like osteomyelitis. |
Safety & Warnings
Common Side Effects
- Ampicillin + Cloxacillin, like other penicillin antibiotics, can cause a range of side effects, varying in severity.
- Common adverse reactions primarily involve the gastrointestinal system, including nausea, vomiting, diarrhea, abdominal pain, and flatulence.
- Cutaneous reactions are also frequent, presenting as skin rashes, which can range from mild maculopapular eruptions (especially notable with ampicillin, particularly in patients with infectious mononucleosis) to more severe hypersensitivity reactions.
- Other reported side effects include candidiasis (oral thrush, vaginal yeast infections) due to alterations in normal microbial flora.
- Less common but more serious adverse events include severe hypersensitivity reactions such as anaphylaxis, angioedema, and urticaria, which require immediate medical intervention.
- Hematological disturbances (e.
- g.
- , anemia, thrombocytopenia, leukopenia, eosinophilia), transient elevations in liver enzymes, and acute interstitial nephritis have also been reported.
- Prolonged use can lead to superinfection with resistant bacteria or fungi, and *Clostridium difficile*-associated diarrhea (CDAD), which can range from mild diarrhea to fatal colitis.
Serious Warnings
- Black Box Warning: While ampicillin + cloxacillin does not carry a formal FDA Black Box Warning in the same manner as some other drug classes, it is imperative to highlight the critical and potentially fatal risk of severe hypersensitivity reactions associated with penicillin antibiotics, including this combination. Penicillins are among the most common causes of drug-induced anaphylaxis, which can manifest as angioedema, laryngeal edema, bronchospasm, circulatory collapse, and even death. These severe reactions are more frequently observed in individuals with a history of penicillin allergy and/or a history of sensitivity to multiple allergens. Healthcare providers must conduct a meticulous and comprehensive inquiry into a patient's allergy history before initiating treatment with ampicillin + cloxacillin. Should any signs or symptoms of a hypersensitivity reaction appear, the medication must be immediately discontinued, and appropriate emergency medical interventions, including but not limited to epinephrine, antihistamines, and corticosteroids, must be administered without delay. Patients should be explicitly counselled on the signs of allergic reactions and advised to seek immediate medical attention if they occur, as failure to do so can result in dire consequences.
- Patients should be thoroughly questioned about previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens before initiating therapy with ampicillin + cloxacillin.
- Severe, sometimes fatal, hypersensitivity (anaphylactic) reactions have been reported with penicillin therapy.
- These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and/or a history of sensitivity to multiple allergens.
- Discontinue the drug immediately if an allergic reaction occurs and institute appropriate therapy.
- The possibility of superinfections with mycotic or bacterial pathogens should be kept in mind during therapy, especially during prolonged use.
- If superinfections occur, appropriate measures should be taken.
- *Clostridium difficile*-associated diarrhea (CDAD) has been reported with the use of nearly all antibacterial agents, including ampicillin + cloxacillin, and may range in severity from mild diarrhea to fatal colitis.
- Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.
- Dosage adjustments are required in patients with renal impairment and hepatic dysfunction should be monitored.
How it Works (Mechanism of Action)
The combination of ampicillin and cloxacillin exerts its bactericidal effects by interfering with bacterial cell wall synthesis. Both antibiotics belong to the beta-lactam class. Ampicillin, an aminopenicillin, works by binding to penicillin-binding proteins (PBPs) located in the bacterial cell wall, thereby inhibiting the transpeptidation step of peptidoglycan synthesis. This disruption leads to defects in the cell wall, increased bacterial cell permeability, and ultimately osmotic lysis and cell death. Ampicillin has a broad spectrum of activity, particularly against Gram-positive bacteria and a range of Gram-negative bacteria, but it is susceptible to degradation by beta-lactamase enzymes produced by certain resistant bacteria. Cloxacillin, an isoxazolyl penicillin, also acts by inhibiting cell wall synthesis through PBP binding. Crucially, cloxacillin is resistant to inactivation by staphylococcal penicillinase (beta-lactamase), which is an enzyme produced by many *Staphylococcus aureus* strains that would otherwise render ampicillin ineffective. The synergistic effect of this combination provides broader coverage, targeting both beta-lactamase-susceptible and beta-lactamase-producing bacterial strains, ensuring efficacy against a wider spectrum of infections.
Commercial Brands (Alternatives)
No other brands found for this formula.